Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
about
Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension.Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models.Milrinone in congenital diaphragmatic hernia - a randomized pilot trial: study protocol, review of literature and survey of current practices.2-AMINOETHYLDIPHENYLBORINATE MODIFIES THE PULMONARY CIRCULATION IN PULMONARY HYPERTENSIVE NEWBORN LAMBS WITH PARTIAL GESTATION AT HIGH ALTITUDE.Persistent Pulmonary Hypertension in the Newborn.
P2860
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
@ast
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
@en
type
label
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
@ast
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
@en
prefLabel
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
@ast
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
@en
P2093
P2860
P1476
Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.
@en
P2093
Bobby Mathew
Corinne L Leach
Satyan Lakshminrusimha
P2860
P304
P356
10.1053/J.SEMPERI.2015.12.004
P577
2016-01-14T00:00:00Z